• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的吡哆醛丙酸酯衍生物作为组织蛋白酶K的特异性抑制剂的体外和体内开发

Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo.

作者信息

Katunuma N, Matsui A, Inubushi T, Murata E, Kakegawa H, Ohba Y, Turk D, Turk V, Tada Y, Asao T

机构信息

Institute for Health Sciences, Tokushima Bunri University, Tokushima, 770-8514, Japan.

出版信息

Biochem Biophys Res Commun. 2000 Jan 27;267(3):850-4. doi: 10.1006/bbrc.1999.1953.

DOI:10.1006/bbrc.1999.1953
PMID:10673380
Abstract

We found that pyridoxal phosphate shows considerable inhibition of cathepsins. CLIK-071, in which the phosphate ester of position 3 of pyridoxal phosphate was replaced by propionate, strongly inhibited cathepsin B. Three new types of synthetic pyridoxal propionate derivatives showing specific inhibition of cathepsin K were developed. New synthetic pyridoxal propionate derivatives, -162, -163, and -164, in which the methyl arm of position 6 of CLIK-071 was additionally modified, strongly inhibited cathepsin K and cathepsin S weakly, but other cathepsins were not inhibited. CLIK-166, in which the position 4 aldehyde of CLIK-071 is replaced by a vinyl radical and position 5 is additionally modified, showed cathepsin K-specific inhibition at 10(-5) M. Pit formation due to bone collagen degradation by cathepsin K of rat osteoclasts was specifically suppressed by administration of CLIK-164, but not by inhibitors of cathepsin L or B.

摘要

我们发现磷酸吡哆醛对组织蛋白酶有显著抑制作用。CLIK-071中,磷酸吡哆醛3位的磷酸酯被丙酸取代,它强烈抑制组织蛋白酶B。开发了三种新型的对组织蛋白酶K有特异性抑制作用的合成吡哆醛丙酸酯衍生物。新型合成吡哆醛丙酸酯衍生物-162、-163和-164,其中CLIK-071 6位的甲基臂被额外修饰,它们强烈抑制组织蛋白酶K,对组织蛋白酶S有较弱抑制作用,但不抑制其他组织蛋白酶。CLIK-166中,CLIK-071的4位醛基被乙烯基取代且5位被额外修饰,它在10(-5) M时表现出对组织蛋白酶K的特异性抑制作用。给予CLIK-164可特异性抑制大鼠破骨细胞的组织蛋白酶K导致的骨胶原降解引起的凹坑形成,但组织蛋白酶L或B的抑制剂则无此作用。

相似文献

1
Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo.基于结构的吡哆醛丙酸酯衍生物作为组织蛋白酶K的特异性抑制剂的体外和体内开发
Biochem Biophys Res Commun. 2000 Jan 27;267(3):850-4. doi: 10.1006/bbrc.1999.1953.
2
Study of the functional share of lysosomal cathepsins by the development of specific inhibitors.通过开发特异性抑制剂研究溶酶体组织蛋白酶的功能份额
Adv Enzyme Regul. 1999;39:247-60. doi: 10.1016/s0065-2571(98)00028-4.
3
Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.大鼠组织蛋白酶K在破骨细胞和吸收陷窝中的定位:肽基乙烯砜对骨吸收和组织蛋白酶K活性的抑制作用
Biol Chem. 1999 Jun;380(6):679-87. doi: 10.1515/BC.1999.084.
4
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.强效且选择性地抑制人组织蛋白酶K可导致非人类灵长类动物体内骨吸收受到抑制。
J Bone Miner Res. 2001 Oct;16(10):1739-46. doi: 10.1359/jbmr.2001.16.10.1739.
5
Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells.基于结构的组织蛋白酶特异性抑制剂的设计及其在保护癌细胞骨转移中的应用。
Arch Biochem Biophys. 2002 Jan 15;397(2):305-11. doi: 10.1006/abbi.2001.2709.
6
Inhibition of intracellular cathepsin activities and suppression of immune responses mediated by helper T lymphocyte type-2 by peroral or intraperitoneal administration of vitamin B6.通过口服或腹腔注射维生素B6抑制细胞内组织蛋白酶活性并抑制2型辅助性T淋巴细胞介导的免疫反应。
Biochem Biophys Res Commun. 2000 May 27;272(1):151-5. doi: 10.1006/bbrc.2000.2738.
7
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys.组织蛋白酶K的一种高效抑制剂(relacatib)在体外以及在猴子体内骨转换升高的急性模型中均能降低骨吸收的生物标志物。
Bone. 2007 Jan;40(1):122-31. doi: 10.1016/j.bone.2006.07.015. Epub 2006 Sep 7.
8
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.半胱氨酸蛋白酶组织蛋白酶K的高效、选择性及口服生物可利用抑制剂的设计
J Med Chem. 2004 Jan 29;47(3):588-99. doi: 10.1021/jm030373l.
9
The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.组织蛋白酶在骨质疏松症和关节炎中的作用:新型治疗药物设计的理论依据。
Adv Drug Deliv Rev. 2005 May 25;57(7):973-93. doi: 10.1016/j.addr.2004.12.013. Epub 2005 Apr 15.
10
A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.一种强效小分子组织蛋白酶K非肽抑制剂(SB 331750)可防止去卵巢大鼠的骨基质吸收。
Bone. 2002 May;30(5):746-53. doi: 10.1016/s8756-3282(02)00675-0.

引用本文的文献

1
Proteases and Osteoporosis: A Comprehensive Review of Their Role in Bone Health.蛋白酶与骨质疏松症:关于其在骨骼健康中作用的全面综述
Curr Drug Targets. 2025;26(7):489-505. doi: 10.2174/0113894501368814250212111828.
2
Lysosomes in Stem Cell Quiescence: A Potential Therapeutic Target in Acute Myeloid Leukemia.干细胞静止状态下的溶酶体:急性髓系白血病的一个潜在治疗靶点
Cancers (Basel). 2022 Mar 23;14(7):1618. doi: 10.3390/cancers14071618.
3
Lysosomes as a therapeutic target.溶酶体作为治疗靶点。
Nat Rev Drug Discov. 2019 Dec;18(12):923-948. doi: 10.1038/s41573-019-0036-1. Epub 2019 Sep 2.
4
Role of proteases in the pathophysiology of cardiac disease.蛋白酶在心脏疾病病理生理学中的作用。
Mol Cell Biochem. 2004 Aug;263(1):241-56. doi: 10.1023/B:MCBI.0000041865.63445.40.
5
Cysteine cathepsins: from structure, function and regulation to new frontiers.半胱氨酸组织蛋白酶:从结构、功能与调控到新前沿领域
Biochim Biophys Acta. 2012 Jan;1824(1):68-88. doi: 10.1016/j.bbapap.2011.10.002. Epub 2011 Oct 12.
6
Structure-based development of specific inhibitors for individual cathepsins and their medical applications.基于结构的个体组织蛋白酶特异性抑制剂的开发及其医学应用。
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(2):29-39. doi: 10.2183/pjab.87.29.